Status:

UNKNOWN

Chromoendoscopy of the Colon After Oral Administration of Indigo Carmine

Lead Sponsor:

Hillel Yaffe Medical Center

Conditions:

Inflammatory Bowel Diseases

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

The purpose of this study is to examine whether oral administration of Indigo Carmine together with Polyethylene Glycol (PEG), the usual colon preparatory solution, can be used instead of staining dur...

Eligibility Criteria

Inclusion

  • Patients suffering from Inflammatory Bowel Disease
  • Patients under surveillance for Disease-Associated Lesions and Masses (DALM)

Exclusion

  • All others

Key Trial Info

Start Date :

August 1 2013

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 1 2013

Estimated Enrollment :

10 Patients enrolled

Trial Details

Trial ID

NCT01914445

Start Date

August 1 2013

End Date

December 1 2013

Last Update

August 2 2013

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Hillel Yaffe Medical Center

Hadera, Israel, 38100